Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Jesse C. Nussbaum, MD

Merck & Co., Inc.

Disclosure(s): Merck & Co.: Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-1245) An Open-Label Phase 1 Study to Evaluate the Effect of Multiple Doses of Rifabutin on the Single-Dose Pharmacokinetics of Ulonivirine in Adults without HIV

Tuesday, October 21, 2025
12:15 PM - 1:30 PM US ET